Immunic Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Immunic
IMUX Stock  USD 1.15  0.03  2.68%   
Immunic financial statements provide useful quarterly and yearly information to potential Immunic investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Immunic financial statements helps investors assess Immunic's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Immunic's valuation are summarized below:
Market Capitalization
103.6 M
Earnings Share
(1.23)
We have found one hundred twenty available fundamental trends for Immunic, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Immunic regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 48.7 M in 2025. Enterprise Value is likely to rise to about (66.2 M) in 2025
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 94.9 K, Interest Expense of 730.2 K or Other Operating Expenses of 119.8 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 1.46. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
  
Check out the analysis of Immunic Correlation against competitors.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Immunic Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets81.3 M62.4 M69.1 M
Slightly volatile
Short and Long Term Debt Total955.9 K1.5 M742.4 K
Slightly volatile
Other Current Liabilities22.9 M21.8 M7.5 M
Slightly volatile
Total Current Liabilities29.9 M28.4 M10.5 M
Slightly volatile
Property Plant And Equipment Net1.4 M1.6 M1.7 M
Pretty Stable
Accounts Payable3.9 M5.9 M3.6 M
Slightly volatile
Cash64 M53.7 M54.7 M
Slightly volatile
Non Current Assets Total1.9 M2 M8 M
Pretty Stable
Cash And Short Term Investments66 M53.7 M56.3 M
Slightly volatile
Common Stock Shares Outstanding53.5 M51 M14.5 M
Slightly volatile
Liabilities And Stockholders Equity81.3 M62.4 M69.1 M
Slightly volatile
Non Current Liabilities Total546.3 K575.1 K8.8 M
Slightly volatile
Other Current Assets4.6 M5.9 M4 M
Slightly volatile
Total Liabilities11.9 M22.8 M17.8 M
Slightly volatile
Property Plant And Equipment Gross1.4 M1.6 M1.7 M
Pretty Stable
Total Current Assets70.8 M60.4 M60.6 M
Slightly volatile
Non Currrent Assets Other36.8 K38.7 K120.3 K
Slightly volatile
Common Stock Total Equity3 K4.6 K2.6 K
Slightly volatile
Common Stock3.1 K4.6 K2.6 K
Slightly volatile
Net Tangible Assets80.6 M130.7 M85.9 M
Pretty Stable
Capital Surpluse326.3 M492.1 M306.8 M
Slightly volatile
Non Current Liabilities Other1.2 M1.1 M475.7 K
Slightly volatile
Property Plant Equipment251.4 K264.6 K1.7 M
Slightly volatile
Other Assets47 K49.5 K157.3 K
Pretty Stable
Net Receivables1.3 M808.5 K865.3 K
Slightly volatile
Intangible Assets23 M37.9 M17.6 M
Slightly volatile
Net Invested Capital31.6 M33.3 M60.3 M
Pretty Stable
Net Working Capital30.4 M32 M52.6 M
Pretty Stable
Capital Stock3.3 K4.6 K3.6 K
Pretty Stable
Capital Lease Obligations1 M1.5 M745.2 K
Slightly volatile

Immunic Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization94.9 K99.9 K617.3 K
Slightly volatile
Other Operating Expenses119.8 M114.1 M55.6 M
Slightly volatile
Research Development100.5 M95.7 M42.8 M
Slightly volatile
Total Operating Expenses119.8 M114.1 M55.6 M
Slightly volatile
Selling General Administrative14 M18.4 M12.6 M
Slightly volatile
Preferred Stock And Other Adjustments7.3 M8.2 M9 M
Slightly volatile
Interest Income3.7 M3.5 M837.5 K
Slightly volatile
Net Interest Income3.7 M3.5 M922.2 K
Slightly volatile
Cost Of Revenue134 K127.7 K42.5 K
Slightly volatile
Reconciled Depreciation94.9 K99.9 K579.2 K
Slightly volatile
Selling And Marketing Expenses88.8 K99.9 K108.9 K
Slightly volatile

Immunic Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation4.4 M8.2 M4 M
Slightly volatile
Begin Period Cash Flow128.9 M122.8 M60.1 M
Slightly volatile
Depreciation94.9 K99.9 K617.3 K
Slightly volatile
Capital Expenditures496.2 K300.6 K554.9 K
Pretty Stable
Total Cash From Financing Activities883.2 K929.7 K29.2 M
Pretty Stable
End Period Cash Flow64 M53.7 M54.7 M
Slightly volatile
Sale Purchase Of Stock110.3 K116.1 K49.8 M
Slightly volatile
Change To Netincome55.1 M52.5 M16.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.3 K19.5 K21.2 K
Slightly volatile
Dividend Yield0.00640.00720.0078
Slightly volatile
Stock Based Compensation To Revenue593667727
Slightly volatile
Capex To Depreciation2.842.711.4259
Slightly volatile
EV To Sales9.7 K10.9 K11.9 K
Slightly volatile
Payables Turnover0.02380.0250.6246
Slightly volatile
Sales General And Administrative To Revenue1.4 K1.6 K1.7 K
Slightly volatile
Research And Ddevelopement To Revenue3.8 K4.3 K4.7 K
Slightly volatile
Capex To Revenue70.4379.2486.3917
Slightly volatile
Cash Per Share1.151.21288
Slightly volatile
Days Payables Outstanding10 K15.1 K8.7 K
Slightly volatile
Income Quality1.020.870.9609
Slightly volatile
Intangibles To Total Assets0.20.210.1972
Slightly volatile
Current Ratio2.322.447.0399
Very volatile
Capex Per Share0.00820.00878.3981
Slightly volatile
Revenue Per Share0.00640.00720.0079
Slightly volatile
Interest Debt Per Share0.03290.0346102
Slightly volatile
Debt To Assets0.02680.02831.1268
Slightly volatile
Days Of Payables Outstanding10 K15.1 K8.7 K
Slightly volatile
Ebt Per Ebit0.740.850.9014
Slightly volatile
Quick Ratio2.322.447.0473
Very volatile
Net Income Per E B T0.861.151.0337
Slightly volatile
Cash Ratio1.611.75.9895
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.121.161.0315
Slightly volatile
Fixed Asset Turnover0.0020.00230.0025
Slightly volatile
Debt Ratio0.02680.02831.1268
Slightly volatile
Price Sales Ratio17.3 K19.5 K21.2 K
Slightly volatile
Asset Turnover1.0E-41.0E-41.0E-4
Slightly volatile

Immunic Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap48.7 M51.2 M250.9 M
Slightly volatile

Immunic Fundamental Market Drivers

Cash And Short Term Investments46.7 M

Immunic Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Immunic Financial Statements

Immunic investors use historical fundamental indicators, such as Immunic's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue7.7 M8 M
Cost Of Revenue127.7 K134 K
Stock Based Compensation To Revenue 666.69  592.61 
Sales General And Administrative To Revenue1.6 K1.4 K
Research And Ddevelopement To Revenue4.3 K3.8 K
Capex To Revenue 79.24  70.43 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue-5.9 K-6.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY